Wednesday, May 28, 2014

GlaxoSmithKline Under Investigation by Serious Fraud Office

The drug maker said the British regulator had opened a formal criminal inquiry into its “commercial practices.” The company gave no further details.








via NYT > Business Day http://ift.tt/1k1eYAB








via WordPress http://ift.tt/1rfCe3b
Posted by at
Labels: , , , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)